Candel Therapeutics Inc (CADL)
ETFs that hold Candel Therapeutics Inc (CADL)
Candel Therapeutics Inc is held by 7 ETFs tracked in our database. The largest position is held by XBI (0.18%), a sector fund. The remaining funds hold it at 0.04% or less. The largest holders are mostly sector and small-cap funds.
ETFs holding Candel Therapeutics Inc (CADL) in our database, ranked by portfolio weight.
Which ETFs hold Candel Therapeutics Inc (CADL)?
The ETFs with the largest positions in Candel Therapeutics Inc (CADL) are: SPDR S&P Biotech ETF (XBI, 0.18%); iShares Russell 2000 Growth ETF (IWO, 0.04%); iShares Biotechnology ETF (IBB, 0.03%); iShares Russell 2000 ETF (IWM, 0.01%); iShares Core S&P Total U.S. Stock Market ETF (ITOT, <0.01%). The full list, ranked by weight, is in the table.
How many ETFs hold Candel Therapeutics Inc (CADL)?
Candel Therapeutics Inc (CADL) is held by 7 ETFs tracked in our database. The largest position is in XBI, where it makes up 0.18% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. XBI holds Candel Therapeutics Inc (CADL) at 0.18%, and the simple average weight across the 7 funds is 0.04%.